Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Thus, this systematic review aimed to evaluate the effect of vitamin D supplementation on relapse rate and magnetic resonance imaging (MRI) disease activity in adults with clinically diagnosed MS.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review
Systematic review · Brain and Behavior · 2026
Original publication title
Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review
© 2026 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Literature evidence links vitamin D supplementation to clinical outcomes in multiple sclerosis (MS), yet no systematic review has focused specifically on relapse rate and MRI activity. Thus, this systematic review aimed to evaluate the effect of vitamin D supplementation on relapse rate and magnetic resonance imaging (MRI) disease activity in adults with clinically diagnosed MS.
Source: IntroductionAbstract: What methods does the paper describe?
This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines. PubMed, Cochrane, EBSCO, and Web of Science were searched for studies discussing vitamin D supplementation in adults with diagnosed MS. Annualized relapse rate (ARR) and changes in MRI activity were the primary outcome measures. Non‐randomized studies and randomized controlled trials were assessed for their risk of bias using the Cochrane ROBINS‐I and RoB‐2 tools, respectively.
Source: MethodsAbstract: Results
Of 304 records identified, 127 duplicates were removed and 177 were screened, with 11 primary studies (14 reports) included after full‐text review. Across studies, vitamin D supplementation did not suggest a reduced ARR with most randomized trials reporting no significant difference between groups. One trial using alfacalcidol provides evidence for a reduction in relapse risk, but this was not replicated. MRI outcomes were more variable, with several studies showing reductions in inflammatory lesion activity, while others found no significant effect.
Overall, results were inconsistent, and due to heterogeneity in study design and reporting, findings were synthesized narratively without meta‐analysis.
Source: ResultsAbstract: Conclusion
Vitamin D supplementation does not consistently reduce relapse rates in adults with MS, although some studies report improvement in MRI activity. The overall certainty of evidence is limited by variation in study design, patient population, cohort size, and risk of bias. Current data does not support vitamin D as a disease‐modifying therapy beyond correction of deficiency; further, larger, standardized trials are needed to clarify its clinical role.
Source: ConclusionAuthors’ abstract
ABSTRACT
Introduction
Literature evidence links vitamin D supplementation to clinical outcomes in multiple sclerosis (MS), yet no systematic review has focused specifically on relapse rate and MRI activity. Thus, this systematic review aimed to evaluate the effect of vitamin D supplementation on relapse rate and magnetic resonance imaging (MRI) disease activity in adults with clinically diagnosed MS.
Methods
This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines. PubMed, Cochrane, EBSCO, and Web of Science were searched for studies discussing vitamin D supplementation in adults with diagnosed MS. Annualized relapse rate (ARR) and changes in MRI activity were the primary outcome measures. Non‐randomized studies and randomized controlled trials were assessed for their risk of bias using the Cochrane ROBINS‐I and RoB‐2 tools, respectively.
Results
Of 304 records identified, 127 duplicates were removed and 177 were screened, with 11 primary studies (14 reports) included after full‐text review. Across studies, vitamin D supplementation did not suggest a reduced ARR with most randomized trials reporting no significant difference between groups. One trial using alfacalcidol provides evidence for a reduction in relapse risk, but this was not replicated. MRI outcomes were more variable, with several studies showing reductions in inflammatory lesion activity, while others found no significant effect.
Overall, results were inconsistent, and due to heterogeneity in study design and reporting, findings were synthesized narratively without meta‐analysis.
Conclusion
Vitamin D supplementation does not consistently reduce relapse rates in adults with MS, although some studies report improvement in MRI activity. The overall certainty of evidence is limited by variation in study design, patient population, cohort size, and risk of bias. Current data does not support vitamin D as a disease‐modifying therapy beyond correction of deficiency; further, larger, standardized trials are needed to clarify its clinical role.
Publication and source details
Original title: Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review
Kamren Hall; Jessica Renteria; Elizabeth Fernandez; Janique Abrahams; Saajan Bhakta
Brain and Behavior · 2026
© 2026 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-08T18:24:42+00:00
DOI: 10.1002/brb3.71692 · PMC13486959